Måndag 17 Augusti | 18:08:12 Europe / Stockholm
Est. tid*
2026-11-06 07:30 Kvartalsrapport 2026-Q3
2026-08-21 07:30 Kvartalsrapport 2026-Q2
2026-05-15 - Kvartalsrapport 2026-Q1
2026-05-11 - X-dag ordinarie utdelning NOSA 0.00 SEK
2026-05-08 - Årsstämma
2026-02-13 - Bokslutskommuniké 2025
2025-11-07 - Kvartalsrapport 2025-Q3
2025-10-23 - Extra Bolagsstämma 2025
2025-08-22 - Kvartalsrapport 2025-Q2
2025-05-15 - Kvartalsrapport 2025-Q1
2025-05-12 - X-dag ordinarie utdelning NOSA 0.00 SEK
2025-05-09 - Årsstämma
2025-02-14 - Bokslutskommuniké 2024
2024-11-08 - Kvartalsrapport 2024-Q3
2024-08-23 - Kvartalsrapport 2024-Q2
2024-05-10 - Kvartalsrapport 2024-Q1
2024-05-06 - X-dag ordinarie utdelning NOSA 0.00 SEK
2024-05-03 - Årsstämma
2024-02-16 - Bokslutskommuniké 2023
2023-12-27 - Extra Bolagsstämma 2023
2023-11-10 - Kvartalsrapport 2023-Q3
2023-08-18 - Kvartalsrapport 2023-Q2
2023-05-12 - Kvartalsrapport 2023-Q1
2023-03-13 - X-dag ordinarie utdelning NOSA 0.00 SEK
2023-03-10 - Årsstämma
2023-02-16 - Bokslutskommuniké 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-10-31 - Extra Bolagsstämma 2022
2022-08-18 - Kvartalsrapport 2022-Q2
2022-05-12 - Kvartalsrapport 2022-Q1
2022-04-22 - X-dag ordinarie utdelning NOSA 0.00 SEK
2022-04-21 - Årsstämma
2022-03-02 - Bokslutskommuniké 2021
2021-11-11 - Kvartalsrapport 2021-Q3
2021-07-15 - Kvartalsrapport 2021-Q2
2021-04-29 - Kvartalsrapport 2021-Q1
2021-03-01 - X-dag ordinarie utdelning NOSA 0.00 SEK
2021-02-26 - Årsstämma
2021-02-25 - Bokslutskommuniké 2020
2020-11-12 - Kvartalsrapport 2020-Q3
2020-11-04 - Extra Bolagsstämma 2020
2020-08-27 - Kvartalsrapport 2020-Q2
2020-05-07 - Kvartalsrapport 2020-Q1
2020-03-27 - X-dag ordinarie utdelning NOSA 0.00 SEK
2020-03-26 - Årsstämma
2020-01-30 - Extra Bolagsstämma 2019
2020-01-27 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-08-29 - Kvartalsrapport 2019-Q2
2019-06-04 - Årsstämma
2019-05-17 - X-dag ordinarie utdelning NOSA 0.00 SEK
2019-05-09 - Kvartalsrapport 2019-Q1
2019-02-21 - Bokslutskommuniké 2018
2018-11-07 - Kvartalsrapport 2018-Q3
2018-08-29 - Kvartalsrapport 2018-Q2
2018-05-17 - Årsstämma
2018-05-09 - Kvartalsrapport 2018-Q1
2018-05-03 - X-dag ordinarie utdelning NOSA 0.00 SEK
2018-02-22 - Bokslutskommuniké 2017
2017-11-15 - Kvartalsrapport 2017-Q3
2017-08-30 - Kvartalsrapport 2017-Q2
2017-05-17 - Kvartalsrapport 2017-Q1
2017-05-04 - X-dag ordinarie utdelning NOSA 0.00 SEK
2017-05-03 - Årsstämma
2017-02-24 - Bokslutskommuniké 2016
2016-11-17 - Kvartalsrapport 2016-Q3
LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Nosa Plugs är verksamt inom medicinteknik. Bolaget är en utvecklare av intranasala andningsprodukter. Produktutbudet är brett och inkluderar exempelvis luktskydd, näsfilter mot luftburna allergener samt nässkydd som används för att reducera virus och bakterier. Produkterna används exempelvis av personer som lider av olika allergier. Störst verksamhet återfinns inom den nordiska marknaden, med huvudkontoret beläget i Stockholm.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

NOSA enters into exclusive distribution agreement with MetroMed for five Middle Eastern markets

2026-08-10 08:30:00

Nosa Plugs AB (publ) (“NOSA”) today announces that the Company has entered into an exclusive distribution agreement with MetroMed regarding the sale of NOSA’s full product portfolio in the United Arab Emirates, Kuwait, Qatar, Oman and Bahrain. In connection with the signing of the agreement, MetroMed will place an initial order for NOSA Odor Control with a value of approximately SEK 330 thousand.

MetroMed is an established distributor of pharmaceuticals, medical devices and healthcare products in the Middle East. The company was founded in 1990, is headquartered in Dubai and is part of Mazrui International, a privately owned group with operations in, among other areas, healthcare, energy, industry and construction.

Under the agreement, MetroMed is granted exclusivity for NOSA’s products in the United Arab Emirates, Kuwait, Qatar, Oman and Bahrain. MetroMed will sell NOSA’s products through its established sales channels, including pharmacies, hospitals, grocery retail and veterinary clinics.

In connection with the signing of the agreement, MetroMed will place an initial order for NOSA Odor Control with an order value of approximately SEK 350 thousand. MetroMed thereafter intends to launch the remaining products in NOSA’s portfolio, including Nozoil, NOSA Smell Training and NOSA Microbial Control, as soon as the required regulatory approvals have been obtained in each respective market. The planned order value for these products following registration amounts to close to SEK 1 million.

The combined value of the initial order and the planned subsequent orders therefore amounts to approximately SEK 1.3 million.

“The MENA region is a market where we see significant long-term potential and where our strategy is to grow together with strong local distributors. MetroMed has the reach, infrastructure and market presence we look for in a partner. The fact that the agreement also covers our entire product portfolio across five markets makes this an important step in our international expansion,” says Adrian Liljefors, CEO, Nosa Plugs AB.

MetroMed distributes products through a network of more than 3,000 points of sale and represents a large number of international brands. The company has an established sales and distribution organisation serving both the healthcare and pharmacy markets, as well as its own warehousing and logistics capabilities.

"We are delighted to partner with NOSA and bring its innovative and high-quality product portfolio to the market. This partnership aligns perfectly with our commitment to providing trusted healthcare solutions and strengthens our ability to deliver innovative products to healthcare professionals and consumers through our well-established distribution network." says Ahmed Saleh, Group Managing Director, Metromed.